Searched for
OPM GROWTH
War, oil and El Nino: Triple threat may cut India Inc's profit margins by 150 bpsIndia Inc faces challenges ahead. Geopolitical tensions in West Asia and El Nino conditions may hurt company profits. Operating profit marg...- Defence stocks set for mixed Q4; Nuvama bets on BEL, Solar Industries, and a smallcap pickDefence sector companies anticipate mixed Q4FY26 results despite strong order books. Nuvama Institutional Equities highlights BEL, Data Pat...
- Grasim Q2 Preview: Double-digit growth in profit, revenue seenRevenue from operations is projected to grow between 17-20% year-on-year, according to estimates from three brokerages, while profit is exp...
- Margin levels of our API to increase once we enter US biz: Amit Rajan, Bajaj HealthcareHowever, the pre-approved inspection has happened for one of the product where it will go to a big pharma para IV product and the supply wi...
- HUL a good pick for long-term, can rally up to 12%: SharekhanHUL is the leader in 80 per cent of its product portfolio with an excellent product development strategy and strong distribution backing. M...
- Buy Sumitomo Chemical, target price Rs 315: ICICI DirectThe brokerage expects animal nutrition business along with CRAMS opportunity to change business mix in the medium to long term.
- Infosys stock stays flat ahead of Q3 dataAll eyes are on any revision in revenue growth guidance and a possible share buyback announcement.
- Infosys Q3 earnings on Friday; market awaits growth guidance, buyback planBrokerages are not expecting any upbeat show from Infosys in Q3.
- L&T Q2 results today: Orders, profit margin key to trackPhillipCapital sees 12 per cent YoY growth in revenues for L&T.
- Buy PTC India, target Rs 100: SharekhanBuy PTC India Ltd. at a price target of Rs 100 with a period of one year for reaching the target.
- Hold Larsen & Toubro Ltd. target Rs 1840 : SharekhanHold Larsen & Toubro Ltd. at a price target of Rs 1840 which can be reached in a year.
- Most of large-cap pharma stocks are pretty balanced in terms of valuation: Sarabjit Kour Nangra, Angel BrokingI believe the overall stock reaction today is in view of the same. Secondly, Sun Pharma management has refrained from giving any guidance f...
- Expect two-wheeler volume to grow substantially: Pawan Goenka, M&M"On the truck side too, M&M had very good growth actually. There was 65% growth compared to the same quarter last year."
- L&T scales above Rs 900 level on strong order book growth in Q2L&T reported a net profit of Rs 977 crore in Q2FY2014, which is ahead of Street estimates, due to a better than estimated operating profit ...
- Dabur Q1 net seen rising 17% to Rs 150 croreDabur India will announce its first quarter results on Monday. The FMCG major is likely to report a net profit of Rs 150 crore.
- Britannia topline seen up 15% on price hikes: Angel BrokingFor the quarter, we expect Britannia to post a decent 15.3 percent YoY growth in its topline to Rs 1,299 crore aided by price hikes.
- Sharekhan revises BASF India price target to Rs 586Bottom line significantly below expectations: BASF India’s stand-alone Q3FY2011 net profit came in at Rs23.7 crore, up 110% year on year (Y...
- Cost control, expansion to hasten growthAn early festive season this year has facilitated a faster recovery in the domestic retail sector. And it is not just the higher sales volu...
- PINC recommends 'hold' on HCCPINC Research has recommended a ‘hold’ on Hindustan Construction Company Ltd (HCC) with a price target of Rs 52.
- PINC maintains 'hold' on Bhushan SteelPINC has downgraded its stock recommendation on Bhushan Steel Ltd to 'hold' and plans to revisit the same once the slab caster and HSM is c...
Load More
